[Importance of a new synthetic vasodilator, Caa 40, in the treatment of chronic ulcers of the lower extremities].
D000013:Congenital Abnormalities; D004423:Ear / Q000002:abnormalities; D004809:Ephedrine / Q000031:analogs & derivatives; D035002:Lower Extremity; D016491:Peripheral Vascular Diseases / Q000628:therapy*; D014456:Ulcer / Q000628:therapy*; D014652:Vascular Diseases; D014665:Vasodilator Agents / Q000628:therapy*
D014665:Vasodilator Agents; D004809:Ephedrine
EPHEDRINE/related compounds; ULCER/therapy; VASCULAR DISEASES, PERIPHERAL/therapy; VASODILATOR AGENTS/therapy